Studies show that GHK-Cu is capable of altering the activity of more than 4,000 genes associated with regeneration, cell protection, and the formation of healthy tissue (Pickart et al., 2015)
Ipamorelin hits the GHRP receptor and says "release GH now." CJC-1295 (no DAC) hits the GHRH receptor and says "amplify that release." When dosed together: CJC-1295 primes the pituitary and increases the available pool of GH Ipamorelin triggers the acute release of that pool The combined pulse is substantially larger than either compound generates alone research suggests synergistic effects in the range of 210x depending on baseline GH status and dosing This works because the two compounds bind to completely separate receptors
By bypassing the digestive system, this method helps reduce ingredient and peptide loss, it also allows the body to access peptides more efficiently than tablets, capsules or topical products
$49.99 CAD, taxes and shipping shown before payment Use Notice: This item is intended for qualified laboratory purchasers only
Other Hormones If you are undergoing testosterone therapy, keep an eye on estradiol levels